RxDoctor Payments Data

Kevin Patterson

Oral and Maxillofacial Surgery · Denver, CONPI 1073681441

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Nobel Biocare USA at 41.9% of the total. Reporting peaked in 2019 at $271 and has fallen 67.5% since, to $88 in 2025. That places this record below the midpoint for oral and maxillofacial surgery clinicians in CO, where the typical reported total is $891.

$998in general payments, 2019–2025

Across 21 payments — averaging $47.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nobel Biocare USA$418
  • Painteq LLC$171
  • Integra Lifesciences Corporation$124
  • Community Blood Center$88
  • Carestream Dental, LLC$63
  • Zimmer Biomet$59
  • plus $76 from 3 others

What the payments were for

  • Food & beverage$98298%
  • Entertainment$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$998 in reported general payments places this provider in the 50th percentile of 159 oral and maxillofacial surgery providers in Colorado.

See all oral and maxillofacial surgery providers in Colorado →

Medicare billing

Part B allowed, 2024
$6,012
Medicare patients
32
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Chlorhexidine Gluconate235$1,407
Amoxicillin213$777
Clindamycin Hcl50$401
Azithromycin40$163
Ondansetron OdtOndansetron20$84
Oxycodone Hcl26$70

Paid to pharmacies, not to this prescriber.

Other oral and maxillofacial surgery in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →